Also categorized in Business of Medicine:
Targeting the Type I Interferon Pathway to Treat Patients With Lupus
x hide permanently

Healthcare Costs Among Patients on Phosphate Binders

Latest Medical Industry News

Photo: Pixabay

The researchers presented results of the study during a poster session as NKF SCM22. The poster was titled Real-World All-Cause Healthcare Costs among Dialysis-Dependent Patients with Chronic Kidney Disease on Phosphate Binders.

The study utilized data from the Centers for Medicare & Medicaid Services (CMS) 100% Research Identifiable File (RIF). Prevalent patients with dialysis-dependent ESKD in the 2018-2019 RIF data were identified. Based on frequency of revenue codes, the patients were divided into hemodialysis and peritoneal dialysis. The researchers assessed monthly phosphate use for calcium acetate, ferric citrate, lanthanum carbonate, sevelamer (hydrochloride and carbonate), and sucroferric oxyhydroxide ...